secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axcella Health Inc. (—)
CIK:        0001633070
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001104659-23-116342
Event type: regulatory
Sentiment:  negative
Materiality: 0.95
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies Axcella of delisting risk; company deemed public shell after board resignations and dissolution plan
--------------------------------------------------------------------------------

- On Nov 8, 2023, Nasdaq Staff notified Axcella it is a 'public shell' due to asset transfer for creditor benefit, dissolution plan, and board/executive departures.
- Ten directors resigned effective Nov 1, 2023, including CEO and Chief Legal Officer; executive team terminated.
- Non-compliance with minimum Market Value of Listed Securities ($50M) and Market Value of Publicly Held Shares ($15M) after 180-day grace period.
- Also non-compliance with independent board and committee composition requirements under Nasdaq Listing Rules 5605.
- Nasdaq Hearings Panel will consider continued listing; company faces potential delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1633070/000110465923116342/0001104659-23-116342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1633070/000110465923116342/tm2330301d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-116342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer